class References {
  constructor(chapterManager) {
    this.chapterManager = chapterManager;
    this.title = "References";
    this.refGutBrain = {
      title: "the gut- brain connection",
      refs: [
        "1) Foster JA, McVey Neufeld K-A. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci (2013) 36:305–12. doi:10.1016/j.tins.2013.01.005",
        "2) Neufeld, K. A. M., Kang, N., Bienenstock, J., & Foster, J. A. (2011). Effects of intestinal microbiota on anxiety-like behavior. Communicative & integrative biology, 4(4), 492-494.",
        "3) Neufeld, K. M., Kang, N., Bienenstock, J., & Foster, J. A. (2011). Reduced anxiety‐like behavior and central neurochemical change in germ‐free mice. Neurogastroenterology & Motility, 23(3), 255-e119.",
        "4) Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X. N., ... & Koga, Y. (2004). Postnatal microbial colonization programs the hypothalamic–pituitary–adrenal system for stress response in mice. The Journal of physiology, 558(1), 263-275.",
        "5) Clarke, G., Grenham, S., Scully, P., Fitzgerald, P., Moloney, R. T., Shanahan, F., ... & Cryan, J. T. (2013). The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Molecular psychiatry, 18(6), 666-673.",
        "6) Avetisyan, M., Schill, E. M., & Heuckeroth, R. O. (2015). Building a second brain in the bowel. The Journal of clinical investigation, 125(3), 899-907.",
        "7) Kim, D. Y., & Camilleri, M. (2000). Serotonin: a mediator of the brain-gut connection. The American journal of gastroenterology, 95(10), 2698.",
        "8) Bonaz, B., Sinniger, V., & Pellissier, S. (2016). Anti‐inflammatory properties of the vagus nerve: potential therapeutic implications of vagus nerve stimulation. The Journal of physiology, 594(20), 5781-5790.",
        "9) Furness, J. B., Callaghan, B. P., Rivera, L. R., & Cho, H. J. (2014). The enteric nervous system and gastrointestinal innervation: integrated local and central control. Microbial endocrinology: The microbiota-gut-brain axis in health and disease, 39-71.",
        "10) Schemann, M. (2005). Control of gastrointestinal motility by the “gut brain”-the enteric nervous system. Journal of pediatric gastroenterology and nutrition, 41, S4-S6.",
        "11) Schemann, M., & Neunlist, M. (2004). The human enteric nervous system. Neurogastroenterology & Motility, 16, 55-59.",
        "12) Hemarajata, P., & Versalovic, J. (2013). Effects of probiotics on gut microbiota: mechanisms of intestinal immunomodulation and neuromodulation. Therapeutic advances in gastroenterology, 6(1), 39-51.",
        "13) Sánchez, B., Delgado, S., Blanco‐Míguez, A., Lourenço, A., Gueimonde, M., & Margolles, A. (2017). Probiotics, gut microbiota, and their influence on host health and disease. Molecular nutrition & food research, 61(1), 1600240.",
        "14) Sanz, Y. (2015). Microbiome and gluten. Annals of Nutrition and Metabolism, 67(Suppl. 2), 27-42",
        "15) Cai, J., Zhang, L., Jones, R. A., Correll, J. B., Hatzakis, E., Smith, P. B., ... & Patterson, A. D. (2016). Antioxidant drug tempol promotes functional metabolic changes in the gut microbiota. Journal of proteome research, 15(2), 563-571.",
        "16) Lange, K., Buerger, M., Stallmach, A., & Bruns, T. (2016). Effects of antibiotics on gut microbiota. Digestive Diseases, 34(3), 260-268.",
      ],
    };
    this.refIntro = {
      title: "introduction",
      refs: [
        "1) Mental Health Foundation. Fundamental Facts About Mental Health. Mental Health Foundation: London. (2016)",
        "2) Salari, N., Hosseinian-Far, A., Jalali, R., Vaisi-Raygani, A., Rasoulpoor, S., Mohammadi, M., ... & Khaledi-Paveh, B. (2020). Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Globalization and health, 16(1), 1-11.",
        "3) WHO. WHO Suicide in the World. WHO (2019).",
        "4) Bell, A., Bennett, A. S., Jones, T. S., Doe-Simkins, M., & Williams, L. D. (2018). Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply. Substance abuse.",
        "5) National Institute of Mental Health. Mental Illness. NIMH (2019)",
        "6) WHO. WHO Depression fact sheet. WHO (2017)",
        "7) WHO | Global status report on noncommunicable diseases 2010. WHO(2011). doi:/entity/nmh/publications/ncd_report2010/en/index.html",
        `8)World Health Organization. "The impact of COVID-19 on mental, neurological and substance use services: results of a rapid assessment." (2020).`,
        "9) Holtzheimer PE, Mayberg HS. Stuck in a rut: rethinking depression and its treatment. Trends in neurosciences. (2011) Jan 1;34(1):1-9",
        `10) Trivedi, M. H. "Rush aJ, Wisniewski SR, Nierenberg Aa, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ et al: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice." The American journal of psychiatry 163 (2006): 28-40.`,
        `11) Al-Harbi, Khalid Saad. "Treatment-resistant depression: therapeutic trends, challenges, and future directions." Patient preference and adherence 6 (2012): 369.`,
      ],
    };
    this.refBreath = {
      title: "the breath",
      refs: [
        "1) Rod K. Observing the effects of mindfulness-based meditation on anxiety and depression in chronic pain patients. Psychiatr Danub (2015) 27(Suppl 1):S209–11",
        "2) Pilkington K, Kirkwood G, Rampes H, Richardson J. Yoga for depression: the research evidence. J Affect Disord (2005) 89:13–24. doi:10.1016/j.jad.2005.08.013",
        "3) hu I-H, Wu W-L, Lin I-M, Chang Y-K, Lin Y-J, Yang P-C. Effects of yoga on heart rate variability and depressive symptoms in women: a randomized controlled trial. J Altern Complement Med (2017) 23:310–6. doi:10.1089/acm.2016.0135",
        "4) Streeter CC, Gerbarg PL, Saper RB, Ciraulo DA, Brown RP. Effects of yoga on the autonomic nervous system, gamma-aminobutyric-acid, and allostasis in epilepsy, depression, and post-traumatic stress disorder. Med Hypotheses (2012) 78:571–9. doi:10.1016/j.mehy.2012.01.021",
        "5) Zope S, Zope R. Sudarshan Kriya yoga: breathing for health. Int J Yoga (2013) 6:4–10. doi:10.4103/0973-6131.105935",
        "6) Sharma A, Barrett MS, Cucchiara AJ, Gooneratne NS, Thase ME. A breathing-based meditation intervention for patients with major depressive disorder following inadequate response to antidepressants: a randomized pilot study. J Clin Psychiatry (2017) 78:e59–63. doi:10.4088/JCP.16m10819",
        "7) Mark E Kunik, Kent Roundy, Connie Veazey, Julianne Souchek, Peter Richardson, Nelda P Wray, Melinda A Stanley, Surprisingly High Prevalence of Anxiety and Depression in Chronic Breathing Disorders,Chest,Volume 127, Issue 4,2005,Pages 1205-1211, ISSN 0012-3692,",
        "8) Kox, M., van Eijk, L. T., Zwaag, J., van den Wildenberg, J., Sweep, F. C., van der Hoeven, J. G., & Pickkers, P. (2014). Voluntary activation of the sympathetic nervous system and attenuation of the innate immune response in humans. Proceedings of the National Academy of Sciences, 111(20), 7379-7384.",
        "9) Grof S. The Adventure of Self-Discovery. Albany, NY: State University of New York Press, 1988.",
        "10) Zwiener U, Lobel S, Rother M, Funke M. Quantitative topographical analysis of EEG during non standardized and standardized hyperventilation. J Clin Neurophysiol 1998;15: 521–528.",
        "11) Settakis G, Lengyel A, Molnar C, et al. Transcranial doppler study of the cerebral hemodynamic changes during breath holding and hyperventilation tests. J Neuroimaging 2002;12: 252–258.",
        "12) Van Diest I, Stegen K, Van de Woestijne KP, et al. Hyperventilation and attention: Effects of hypocapnia on performance in a stroop task. Biol Psychol 2000;53:233–252.",
        "13) Agadzhanyan NA, Panina MI, Kozupitsa GS, Sergeev OS. Subjective and neurological manifestations of hyperventilation states of different intensities. Hum Physiol 2003;29:66–71.",
        "14) Terekhin PI . The role of hypocapnia in inducing altered states of consciousness. Hum Physiol 1996;22:730–735.",
        "15) Dietrich A. Functional neuroanatomy of altered states of consciousness: The transient hypofrontality hypothesis. Conscious Cogn 2003;12:231–256",
        "16) Vaitl D, Birbaumer N, Gruzelier J, et al. Psychobiology of altered states of consciousness. Psychol Bull 2005;131:98–127",
        "17) Dietrich, A. (2006). Transient hypofrontality as a mechanism for the psychological effects of exercise. Psychiatry research, 145(1), 79-83",
        "18) Rhinewine, J. P., & Williams, O. J. (2007). Holotropic breathwork: The potential role of a prolonged, voluntary hyperventilation procedure as an adjunct to psychotherapy. The Journal of Alternative and Complementary Medicine, 13(7), 771-776.",
        "19) Miller, T., & Nielsen, L. (2015). Measure of significance of holotropic breathwork in the development of self-awareness. The Journal of Alternative and Complementary Medicine, 21(12), 796-803.",
        "20) Walton, K. G., Pugh, N. D., Gelderloos, P., & Macrae, P. (1995). Stress reduction and preventing hypertension: preliminary support for a psychoneuroendocrine mechanism. The journal of alternative and complementary medicine, 1(3), 263-283",
      ],
    };
    this.refPsychedelics = {
      title: "psychedelics",
      refs: [
        "1) Hofmann, A., & Schultes, R. E. (1979). Plants of the gods: Origins of hallucinogenic use. Maidenhead, UK: McGraw-Hill Book Company.",
        "2) Vollenweider, F. X., & Kometer, M. (2010). The neurobiology of psychedelic drugs: implications for the treatment of mood disorders. Nature Reviews Neuroscience, 11(9), 642-651.",
        "3) Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014). Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of psychopharmacology, 28(11), 983-992",
        "4) Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P. C. R., & Strassman, R. J. (2015). Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study. Journal of psychopharmacology, 29(3), 289-299.",
        "5) Krebs, T. S., & Johansen, P. Ø. (2012). Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials. Journal of Psychopharmacology, 26(7), 994-1002.",
        "6) Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011). The safety and efficacy of±3, 4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study. Journal of psychopharmacology, 25(4), 439-452.",
        "7) Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., Martin, S. F., Yazar-Klosinski, B., ... & Doblin, R. (2013). Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3 ,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study. Journal of psychopharmacology, 27(1), 28-39.",
        "8) Ot’alora G, M., Grigsby, J., Poulter, B., Van Derveer III, J. W., Giron, S. G., Jerome, L., ... & Doblin, R. (2018). 3, 4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: a randomized phase 2 controlled trial. Journal of Psychopharmacology, 32(12), 1295-1307.",
        "9) Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M., Erritzoe, D., Kaelen, M., ... & Nutt, D. J. (2016). Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry, 3(7), 619-627.",
        "10) Osório, F. D. L., Sanches, R. F., Macedo, L. R., Dos Santos, R. G., Maia-de-Oliveira, J. P., Wichert-Ana, L., ... & Hallak, J. E. (2015). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report. Brazilian Journal of Psychiatry, 37(1), 13-20.",
        "11) Grob, C. S., Danforth, A. L., Chopra, G. S., Hagerty, M., McKay, C. R., Halberstadt, A. L., & Greer, G. R. (2011). Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer. Archives of general psychiatry, 68(1), 71-78.",
        "12) Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., ... & Schmidt, B. L. (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial. Journal of psychopharmacology, 30(12), 1165-1180.",
        "13) Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., ... & Klinedinst, M. A. (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of psychopharmacology, 30(12), 1181-1197.",
        "14) Gasser, P., Holstein, D., Michel, Y., Doblin, R., Yazar-Klosinski, B., Passie, T., & Brenneisen, R. (2014). Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases. The Journal of nervous and mental disease, 202(7), 513.",
        "15) Kyzar, E. J., Nichols, C. D., Gainetdinov, R. R., Nichols, D. E., & Kalueff, A. V. (2017). Psychedelic drugs in biomedicine. Trends in pharmacological sciences, 38(11), 992-1005.",
        "16) Frokjaer, V. G., Mortensen, E. L., Nielsen, F. Å., Haugbol, S., Pinborg, L. H., Adams, K. H., ... & Knudsen, G. M. (2008). Frontolimbic serotonin 2A receptor binding in healthy subjects is associated with personality risk factors for affective disorder. Biological psychiatry, 63(6), 569-576.",
        "17) Amat, J., Baratta, M. V., Paul, E., Bland, S. T., Watkins, L. R., & Maier, S. F. (2005). Medial prefrontal cortex determines how stressor controllability affects behavior and dorsal raphe nucleus. Nature neuroscience, 8(3), 365-371.",
        "18) Clark, L., Chamberlain, S. R., & Sahakian, B. J. (2009). Neurocognitive mechanisms in depression: implications for treatment. Annual review of neuroscience, 32(1), 57-74.",
        "19) Bishop, S. J. (2008). Neural mechanisms underlying selective attention to threat. Annals of the New York Academy of Sciences, 1129(1), 141-152.",
        "20) Johnstone, T., Van Reekum, C. M., Urry, H. L., Kalin, N. H., & Davidson, R. J. (2007). Failure to regulate: counterproductive recruitment of top-down prefrontal-subcortical circuitry in major depression. Journal of Neuroscience, 27(33), 8877-8884.",
        "21) DeRubeis, R. J., Siegle, G. J., & Hollon, S. D. (2008). Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nature Reviews Neuroscience, 9(10), 788-796.",
        "22) Martinowich, K., Manji, H., & Lu, B. (2007). New insights into BDNF function in depression and anxiety. Nature neuroscience, 10(9), 1089-1093.",
        "23) Krystal, J. H., Tolin, D. F., Sanacora, G., Castner, S. A., Williams, G. V., Aikins, D. E., ... & D'Souza, D. C. (2009). Neuroplasticity as a target for the pharmacotherapy of anxiety disorders, mood disorders, and schizophrenia. Drug discovery today, 14(13-14), 690-697.",
        "24) Garcia-Romeu, A., R Griffiths, R., & W Johnson, M. (2014). Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction. Current drug abuse reviews, 7(3), 157-164.",
        "25) MacLean, K. A., Johnson, M. W., & Griffiths, R. R. (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25(11), 1453-1461.",
        "26) Roseman, L., Nutt, D. J., & Carhart-Harris, R. L. (2018). Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in pharmacology, 8, 974.",
        "27) Griffiths, R. R., Richards, W. A., Johnson, M. W., McCann, U. D., & Jesse, R. (2008). Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later. Journal of psychopharmacology, 22(6), 621-632.",
        "28) Palhano-Fontes, F., Andrade, K. C., Tofoli, L. F., Santos, A. C., Crippa, J. A. S., Hallak, J. E., ... & de Araujo, D. B. (2015). The psychedelic state induced by ayahuasca modulates the activity and connectivity of the default mode network. PloS one, 10(2), e0118143.",
        "29) Muthukumaraswamy, S. D., Carhart-Harris, R. L., Moran, R. J., Brookes, M. J., Williams, T. M., Errtizoe, D., ... & Nutt, D. J. (2013). Broadband cortical desynchronization underlies the human psychedelic state. Journal of Neuroscience, 33(38), 15171-15183",
        "30) Grof, S. (1980). LSD psychotherapy. Hunter House.",
        "31) Hoffer, A. (1965). D‐Lysergic acid diethylamide (LSD): A review of its present status. Clinical Pharmacology & Therapeutics, 6(2), 183-255.",
        "32) Kaelen, M., Lorenz, R., Barrett, F., Roseman, L., Orban, C., Santos-Ribeiro, A., ... & Leech, R. (2017). Effects of LSD on music-evoked brain activity. BioRxiv, 153031.",
        "33) Kaelen, M., Roseman, L., Kahan, J., Santos-Ribeiro, A., Orban, C., Lorenz, R., ... & Carhart-Harris, R. (2016). LSD modulates music-induced imagery via changes in parahippocampal connectivity. European Neuropsychopharmacology, 26(7), 1099-1109.",
        "34) Preller, K. H., Herdener, M., Pokorny, T., Planzer, A., Kraehenmann, R., Stämpfli, P., ... & Vollenweider, F. X. (2017). The fabric of meaning and subjective effects in LSD-induced states depend on serotonin 2A receptor activation. Current Biology, 27(3), 451-457.",
        "35) Belser, A. B., Agin-Liebes, G., Swift, T. C., Terrana, S., Devenot, N., Friedman, H. L., ... & Ross, S. (2017). Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis. Journal of Humanistic Psychology, 57(4), 354-388",
        "36) Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., ... & Carhart-Harris, R. (2018). The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology, 235(2), 505-519.",
      ],
    };
    this.refMusic = {
      title: "music",
      refs: [
        "1) Kaelen, M., Giribaldi, B., Raine, J., Evans, L., Timmerman, C., Rodriguez, N., ... & Carhart-Harris, R. (2018). The hidden therapist: evidence for a central role of music in psychedelic therapy. Psychopharmacology, 235(2), 505-519.",
        "2) Fachner, J. (2011). Time is the key–music and altered states of consciousness. Altering consciousness: A multidisciplinary perspective, 1, 355-376.",
      ],
    };
    this.songs = {
      title: "music",
      refs: [
        "Pain: nthng - Unfinished ",
        "The problem: nthng - Subnautica",
        "The beauty of science: AYYA - Second Mistake",
        "The Gut-Brain axis: Donato Dozzy - Vaporware",
        "The Breath: Joshua Sam Miller - Sit",
        "Psychedelics: nthng - Wave Return",
        "Sound: Lawrence Laughing - Waterlife",
        "Some Thoughts: nthng - And then there was light",
        "References: Nicolas Jaar - Hello, chain",
      ],
    };
    this.goodbye = {
      title: "thanks for your time and attention",
      refs: [
        "this project was created in p5.js",
        "take care",
        "www.noam-rubin.com",
      ],
    };
    this.references = [
      this.refIntro,
      this.refGutBrain,
      this.refBreath,
      this.refPsychedelics,
      this.refMusic,
      this.songs,
      this.goodbye,
    ];
    this.y = 200;
  }

  preload() {
    this.mySound = loadSound("assets/songs/hellochain.mp3");
  }

  setup() {
    this.textWidth = 200;
  }

  draw() {
    background(0);
    fill("gray");
    textSize(60);
    textAlign(CENTER, CENTER);
    text(this.title, windowWidth / 2, 80);
    this.references.forEach((topic, index) => {
      textSize(21);
      let multiply;
      if (topic === this.refMusic && this.songs) {
        multiply = 2400;
      } else {
        multiply = 2000;
      }
      this.titlePosY = this.y + index * multiply;
      text(topic.title, windowWidth / 2, this.titlePosY);
      textSize(16);
      topic.refs.forEach((ref, index) => {
        return text(
          ref,
          windowWidth / 2 - windowWidth / 2.4,
          this.titlePosY + 100 + index * 90,
          windowWidth / 1.2
        );
      });
    });
  }

  mouseWheel(event) {
    //  move text
    if (event.deltaY > 0) {
      this.y -= 20;
    } else {
      this.y += 20;
    }

    //  play music
    if (!this.mySound.isPlaying()) {
      this.mySound.play();
    }
    clearTimeout(this.isScrolling);
    this.mySound.setVolume(2);

    // pause music on stop scroll
    this.isScrolling = setTimeout(() => {
      // this.mySound.pause();
      this.mySound.setVolume(0.8);
    }, 1000);

    this.pos += event.delta;
  }

  mousePressed() {
    print("thanks");
  }
}
